Research article
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins
-
* Corresponding author: Tomohiko Ohta to@marianna-u.ac.jp
1 Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine, Kawasaki, 216-8511 Japan
2 Department of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, 216-8511 Japan
3 Department of Diagnostic Pathology, St. Marianna University School of Medicine, Kawasaki, 216-8511 Japan
4 Department of Breast and Endocrine Surgery, Kumamoto University, Honjo 1-1-1, Kumamoto 860-8556, Japan
Breast Cancer Research 2010, 12:R17 doi:10.1186/bcr2486
Published: 5 March 2010Additional files
Additional file 1:
Table S1. Antibodies used in the present immunohistochemical study.
Format: PDF Size: 35KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 2:
Figure S1. Mean tumor volume reduction after EC (a) or EC+DOC (b) according to the nuclear foci status for DNA repair proteins.
Format: PDF Size: 123KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 3:
Table S2. Tumor response rate according to the nuclear foci status for DNA repair proteins.
Format: PDF Size: 55KB Download file
This file can be viewed with: Adobe Acrobat Reader